Nuzenio

Claris Bio Raises

Claris Bio Raises news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 6 latest news signals 6 publisher sources 100/100 entity strength

Latest news

Timeline

Mon, 03 Aug 2026 19:26:06 GMTClaris Bio raises $118M to advance first-ever LSCD therapy - Glance by Eyes On Eyecare
Wed, 29 Jul 2026 18:58:34 GMTClaris Bio Raises $118M to Take Eye Drop for Blindness into Phase III - Inside Precision Medicine
Wed, 29 Jul 2026 07:00:00 GMTClaris Bio raises $118m for eye disease therapy - BioXconomy
Tue, 28 Jul 2026 07:00:00 GMTAn eye drug biotech banks $118M and stocks its executive suite - BioPharma Dive
Tue, 28 Jul 2026 07:00:00 GMTClaris Bio raises USD 118m to advance first-ever pharmacologic therapy for limbal stem cell deficiency - AllSci
Tue, 28 Jul 2026 07:00:00 GMTClaris Bio Unveils Development Strategy, Planned Pivotal Study Supported by $118 Million Series B Financing from Top-Tier Investors, and Multiple Leadership Appointments - The Manila Times

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Claris Bio Raises.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

6 distinct publisher/source names are currently connected to this entity page.